<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6)
The Female Health Company
--------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
--------------------------------------------------------------
(Title of Class of Securities)
314462 10 2
--------------------------------------------------------------
(CUSIP Number)
Stephen M. Dearholt
741 N. Milwaukee Street, Suite 500, Milwaukee, Wisconsin 53202
--------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 15, 2000
--------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box [_].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
-----------------------
CUSIP NO. 314462 10 2
-----------------------
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only).
Stephen M. Dearholt
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
2 (a) [_]
(b) [_]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS (See Instructions)
4
PF
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Wisconsin, USA
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 2,064,585
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
640,998
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 2,064,585
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
640,998
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
2,705,583
------------------------------------------------------------------------------
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_]
12
(See Instructions)
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
20.29%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (See Instructions)
14
IN
------------------------------------------------------------------------------
------------------------------------------------------------------------------
------------------------------------------------------------------------------
------------------------------------------------------------------------------
------------------------------------------------------------------------------
------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
This amendment is being filed to report the acquisition of additional
shares of common stock ("Issuer Common Stock") of The Female Health Company (the
"Company") by Mr. Dearholt as described in Item 5.
Item 5. Interest in Securities of the Issuer
<TABLE>
<CAPTION>
Amount of Beneficial Ownership
Shares of Percent
Name of Beneficial Owner Issuer Common
Stock
<S> <C> <C>
Stephen M. Dearholt (1)(2) 2,705,583 20.29%
</TABLE>
(1) Includes options to purchase 50,000 shares (which are currently
exercisable) granted pursuant to the terms of the Company's Outside
Director Stock Option Plan.
(2) Includes 733,605 shares owned directly by Mr. Dearholt and warrants to
purchase 1,172,500 shares which are currently exercisable. Also includes
the following shares which Mr. Dearholt may be deemed to beneficially own:
69,500 shares held by the Dearholt, Inc. Profit Sharing Plan; 9,680 shares
held by the Response Marketing Money Purchase Plan; 11,200 shares held in a
self-directed IRA; 162,898 shares held by the Mary C. Dearholt Trust of
which Mr. Dearholt, a sibling and his mother are trustees; 18,100 shares
held by Mr. Dearholt's minor child; 418,100 shares held by the James W.
Dearholt Trust of which Mr. Dearholt is a co-trustee with a sibling, and
60,000 shares of preferred stock held by the Mary C. Dearholt Trust that
are convertible share-for-share into Issuer Common Stock. Mr. Dearholt
shares the power to vote and dispose of 640,998 shares of Issuer Common
Stock (including 60,000 shares of Preferred Stock convertible into Issuer
Common Stock) held by the Mary C. Dearholt Trust and the James W. Dearholt
Trust. Mr. Dearholt has sole power to vote and dispose of the remaining
shares of Issuer Common Stock reported herein, except that North Central
Trust has the sole power to vote and dispose of the 9,680 shares of Issuer
Common Stock held by the Response Marketing Money Purchase Plan.
On November 15, 2000, Stephen Dearholt purchased 208,863 shares of Issuer
Common Stock on the market at $.40 per share. All shares were purchased solely
for investment purposes.
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ Stephen M. Dearholt
-----------------------------
Stephen M. Dearholt
Dated: November 21, 2000
